Shinji Sugiura

Dr. Shinji Sugiura

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2001 in Langmuir
Verified
Journal Article
Closed access
SSShinji Sugiura
Shinji Sugiura
MNMitsutoshi Nakajima
Mitsutoshi Nakajima
SISatoshi Iwamoto
Satoshi Iwamoto
MSMinoru Seki
Minoru Seki

1 June 2005 in Biomaterials
Verified
Journal Article
Closed access
SSShinji Sugiura
Shinji Sugiura
TOTatsuya Oda
Tatsuya Oda
YIYasuhiko Izumida
Yasuhiko Izumida
YAYasuyuki Aoyagi
Yasuyuki Aoyagi
MSMitsuo Satake
Mitsuo Satake
MNMitsutoshi Nakajima
Mitsutoshi Nakajima

1 July 2000 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
SSShinji Sugiura
Shinji Sugiura
MNMitsutoshi Nakajima
Mitsutoshi Nakajima
JTJihong Tonga
Jihong Tonga
HNHiroshi Nabetania
Hiroshi Nabetania
MSMinoru Sekib
Minoru Sekib

15 August 2002 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
SSShinji Sugiura
Shinji Sugiura
MNMitsutoshi Nakajima
Mitsutoshi Nakajima
NKNaoyuki Kumazawa
Naoyuki Kumazawa
SISatoshi Iwamoto
Satoshi Iwamoto
MSMinoru Seki
Minoru Seki

14 November 2017 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
TST. Satoh
T. Satoh
SSShinji Sugiura
Shinji Sugiura
KSK. Shin
K. Shin
ROR. Onuki-Nagasaki
R. Onuki-Nagasaki
SIS. Ishida
S. Ishida
TKT. Kanamori
T. Kanamori
This paper reports a multi-throughput multi-organ-on-a-chip system formed on a pneumatic pressure-driven medium circulation platform with a microplate-sized format as a novel type of microphysiological system. The pneumatic pressure-driven platform enabled parallelized multi-organ experiments (i.e. simultaneous operation of multiple multi-organ culture units) and pipette-friendly liquid handling for various conventional cell culture experiments, including cell seeding, medium change, live/dead staining, cell growth analysis, gene expression analysis of collected cells, and liquid chromatography–mass spectrometry analysis of chemical compounds in the culture medium. An eight-throughput two-organ system and a four-throughput four-organ system were constructed on a common platform, with different microfluidic plates. The two-organ system, composed of liver and cancer models, was used to demonstrate the effect of an anticancer prodrug, capecitabine (CAP), whose metabolite 5-fluorouracil (5-FU) after metabolism by HepaRG hepatic cells inhibited the proliferation of HCT-116 cancer cells. The four-organ system, composed of intestine, liver, cancer, and connective tissue models, was used to demonstrate evaluation of the effects of 5-FU and two prodrugs of 5-FU (CAP and tegafur) on multiple organ models, including cancer and connective tissue.

22 June 2002 in Langmuir
Verified
Journal Article
Closed access
SSShinji Sugiura
Shinji Sugiura
MNMitsutoshi Nakajima
Mitsutoshi Nakajima
MSMinoru Seki
Minoru Seki